Sha Yuan Zi

Astragalus complanatus R. Br.

Also known as: Flattened Milkvetch Seed(English) 沙苑子(Chinese)

Sawonja沙苑子 사원자 Sha Yüan Tzŭ

Updated October 5, 2026 · Not yet clinically reviewed

Safety at a glance

Note

3 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
tonifying
Temperature
Warm
Taste
Sweet
Channels
Liver,Kidney

Functions

Tonifies Kidney Yang; Secures Essence and Stops Enuresis; Nourishes the Liver and Brightens the Eyes

Traditional uses

Sha Yuan Zi (astragalus complanatus seed) is a gentle, warm herb that tonifies Liver and Kidney, consolidates Jing, and brightens the eyes. It is used for spermatorrhea, impotence, excessive vaginal discharge, frequent urination, and lower back weakness arising from deficiency of Liver and Kidney. Its secondary action of brightening the eyes makes it appropriate when visual changes accompany Kidney-Liver deficiency patterns.

Western herbalism

Properties: tonic, astringent

Pharmacological effects

  • Immunologic: Decoction 5 g/kg orally for 10 days in mice raised serum lysozyme and splenic lymphocyte transformation but not macrophage or NK activity.
  • Anti-inflammatory and analgesic: Alcohol-precipitated decoction (APD) inhibited formaldehyde, carrageenin and histamine edema in rats, mainly via antihistamine action rather than pituitary-adrenal axis; analgesic in hot-plate and writhing tests.
  • Cardiovascular and hemorheologic: APD i.v. was hypotensive in dogs and rats; total flavonoids i.v. lowered BP and relaxed noradrenaline-contracted aorta; total flavonoids lowered serum lipids, improved blood rheology and inhibited ADP/collagen platelet aggregation.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 621.

Formulas using this herb

4 of 4 formulas

Botanical

Astragalus complanatus is a low-growing perennial herb in the Fabaceae family, native to northern and central China and parts of Mongolia, where it grows on dry, sandy slopes and grasslands. The plant has prostrate or ascending stems, 20-100 cm long, branching from a woody base, and is covered with fine appressed hairs. The alternate, pinnately compound leaves bear 9-21 small elliptic to oblong leaflets, each 5-15 mm long, with entire margins. Small pale yellow pea-like flowers are borne in short axillary racemes in summer, followed by inflated, curved, papery legumes 2-3 cm long containing several seeds. The mature seeds (Sha Yuan Zi) are reniform, slightly flattened, 2-3 mm long, smooth, and greenish-brown to brownish-black. In TCM, they are used as a sweet, warm herb that tonifies the kidneys, secures essence, and improves vision.

Family
Fabaceae
Pharmaceutical name
Semen Astragali Complanati
Parts used
seed
Plant type
herb
Native region
Shaanxi, Shanxi

Constituents

Complanatuside (complanatoside A)

Flavonol (myricetin-type) glycoside · 0.062-0.134% of authentic commercial seed samples; the Chinese Pharmacopoeia and the Taiwan Herbal Pharmacopeia both set a minimum of 0.06%, and the compound was undetectable in market samples identified as adulterants

The official marker compound for Semen Astragali Complanati and the basis of its identity assay, so its absence is used to expose substituted material. It is extensively metabolised after oral dosing, with glucuronidation and sulfonation the major routes and more than thirty metabolites detected in rat plasma and excreta, which means systemic exposure to the parent glycoside is low.

Myricetin and its glycosides

Flavonol and flavonol glycosides · not quantified; present alongside complanatuside in the seed

In the isolation study of commercial Astragali Complanati Semen, two myricetin-derived glycosides showed greater antioxidant and anti-inflammatory activity in vitro than complanatuside itself, so the official marker compound is not necessarily the most active constituent of the drug.

Astragalin (kaempferol-3-O-glucoside)

Flavonol glycoside · not quantified in the drug

A widely distributed flavonol glucoside reported among the seed flavonoids. Despite the name it is not distinctive to the genus and carries no evidence of a specific clinical effect at seed-level exposures.

Rhamnocitrin-3-O-beta-D-glucoside

Methylated flavonol glycoside · not quantified in the drug

One of the methylated flavonol glycosides reported from the seed. It is of interest mainly as part of the flavonoid fingerprint used to distinguish authentic material from adulterants.

Soyasaponin I

Oleanane triterpene saponin · not quantified in the drug

A legume-typical triterpene glycoside occurring in the seed. It contributes to the surfactant and mildly irritant character of a saponin-bearing seed drug; no clinical effect has been attributed to it at dispensing doses.

Polysaccharides

Plant polysaccharides · not quantified; listed among the major constituent classes of the seed

Reported as one of the bulk constituent classes of the drug. Antioxidant and immunomodulatory activity has been claimed for Astragalus polysaccharides generally, but the data are not specific to Astragalus complanatus seed and should not be carried over from Huang Qi.

Fatty acids

Seed lipids · not quantified; listed among the major constituent classes

As with other legume seeds a substantial part of the dry weight is fixed oil. This is pharmacologically inert at dispensing doses but is relevant to storage: rancidity is the practical quality problem with old Sha Yuan Zi.

Drug interactions

Astragalus adsurgens seed, the documented market adulterant of Sha Yuan Zi

Moderate · A different Astragalus seed with no complanatuside is dispensed as Sha Yuan Zi; the expected drug is simply absent · Evidence level: Established

Astragalus adsurgens seed is the commonest adulterant of Astragali Complanati Semen because the two seeds are almost indistinguishable by eye; they separate reliably only on seed-coat and hilum microstructure, on the distribution of fat droplets in the cotyledon cells, or on chromatographic fingerprint. In a survey of eleven market samples from Taiwan, two southern samples had HPLC fingerprints unlike the rest and no detectable complanatuside, i.e. they were adulterants. A patient given such material receives none of the flavonoid fraction on which the drug's identity and reported activity rest.

Clinical note: Buy Sha Yuan Zi on a complanatuside assay (minimum 0.06%) or a fingerprint certificate rather than on appearance. Unexplained non-response to a Sha Yuan Zi-containing formula should raise the possibility of substituted seed before the dose is increased.

Huang Qi (Astragalus membranaceus root, Radix Astragali) and its documented drug interactions

Moderate · The two drugs are confused because they share a genus and a pinyin family, but they are a seed and a root with different constituents, different indications and different interaction profiles · Evidence level: Established

Sha Yuan Zi is the ripe seed of Astragalus complanatus (Semen Astragali Complanati), a Kidney-securing drug assayed on complanatuside. Huang Qi is the root of Astragalus membranaceus, a Qi-tonifying drug assayed on astragaloside IV and Astragalus polysaccharides, and it is Huang Qi, not Sha Yuan Zi, for which immunostimulant activity and the resulting theoretical opposition to immunosuppressants such as ciclosporin and tacrolimus have been discussed. Neither drug's data transfer to the other. Note also that the taxonomic literature cites this species under more than one authority, Astragalus complanatus R. Br. and Astragalus complanatus Bunge, which further muddles catalogue matching; both refer to the same flatstem milkvetch seed.

Clinical note: Do not apply Huang Qi cautions or Huang Qi expectations to Sha Yuan Zi, and check on dispensing records that a prescription for one has not been filled with the other. The two are visually unmistakable, a seed against a sliced root, so the error is a labelling and ordering error, not a substitution that survives inspection.

Lipid-lowering drugs (statins, fibrates)

Minor · Possible additive reduction in serum cholesterol; no reported adverse consequence · Evidence level: Theoretical

An extract of Astragali Complanati Semen lowered raised cholesterol in rats on a high-cholesterol diet, with metabolomic evidence pointing to upregulation of hepatic PPAR-alpha and increased fatty-acid oxidation, and a flavonoid fraction of the seed reduced markers of collagen synthesis and lipid peroxidation in rats with dimethylnitrosamine-induced hepatic fibrosis at 30-120 mg/kg. Both findings are rodent-only. No human pharmacokinetic or pharmacodynamic study of this drug with a statin or fibrate exists, and no CYP or transporter data are available for the seed, so an interaction is inferred from shared direction of effect alone.

Clinical note: No action needed beyond the usual lipid monitoring. Do not present Sha Yuan Zi as a lipid-lowering agent to a patient on a statin; the supporting evidence is animal data and does not justify altering the drug.

Dosage

FormAmountFrequencyNotes
decoction9–15 gDaily
中国药典 2020 【用法与用量】9~15g。 【性味与归经】甘,温。归肝、肾经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
3

Bioactive Flavonoid Glycosides and HPLC and UPLC Quantification of Commercial Astragali Complanati Semen

Kuo JC-L, Zhang L-J, Huang H-T, Liaw C-C, Lin Z-H, Liu M, Kuo Y-H · Molecules · 2020 · in vitro

In vitro / animal · Not yet verified

Eleven compounds, nine of them flavonoid glycosides plus one isoflavone glycoside, were isolated from Astragali Complanati Semen and quantified by HPLC and UPLC in eleven commercial samples from Taiwan. Complanatuside ranged from 0.062% to 0.134%, meeting the 0.06% minimum of both the Chinese and Taiwan pharmacopoeias, while two southern samples had aberrant fingerprints and no detectable complanatuside and were identified as adulterants. Two myricetin-derived glycosides were more active than complanatuside in the antioxidant and anti-inflammatory assays used.

doi:10.3390/molecules25204762

Quantification of complanatoside A in rat plasma using LC-MS/MS and its application to a pharmacokinetic study

Li N, Liu Y, Cao Y, Wei Z, Pang L, Wang J · Biomedical Chromatography · 2015 · animal

In vitro / animal · Not yet verified

A validated LC-MS/MS assay was developed for complanatoside A, the flavonol glycoside used as the Chinese Pharmacopoeia quality index for Astragalus complanatus, over 2.3-575 ng/mL in rat plasma, and applied to a pharmacokinetic study. The low plasma concentrations reported are consistent with extensive first-pass conjugation of the marker glycoside and caution against assuming that the assayed constituent is the circulating active.

doi:10.1002/bmc.3624

Effect ofAstragalus complanatusflavonoid on anti-liver fibrosis in rats

Liu CY, Gu ZL, Zhou WX, Guo CY · World Journal of Gastroenterology · 2005 · animal

In vitro / animal · Verified

Hepatic fibrosis was induced in rats with dimethylnitrosamine and Astragalus complanatus flavonoids were given at 30, 60 and 120 mg/kg once daily for one month. Superoxide dismutase activity rose and malondialdehyde fell relative to the model group, and serum PINP and PIIINP, markers of collagen synthesis, fell in the higher-dose groups. This is rodent evidence for an antifibrotic and antioxidant effect of an isolated flavonoid fraction, not of the dispensed seed, and there is no human counterpart.

doi:10.3748/wjg.v11.i37.5782

Safety

Contraindications

Its use is prohibited in patients with vigorous fire due to yin deficiency, and difficulty in micturition.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 344–356.

Side effects

  • No abnormalities in blood, liver/kidney function or organ histology in rats given the herb orally for 60 days.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 621.

Cultural and historical

Ben Cao Yan Yi

Earliest recorded in Extension of the Materia Medica per Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 344–356.

References

  1. Ng YF, Tang PC-T, Sham TT, Lam WS, Mok DK-W, Chan SW. Semen Astragali Complanati: An ethnopharmacological, phytochemical and pharmacological review. Journal of Ethnopharmacology. 2014 doi:10.1016/j.jep.2014.06.013
  2. Kuo JC-L, Zhang L-J, Huang H-T, Liaw C-C, Lin Z-H, Liu M, Kuo Y-H. Bioactive Flavonoid Glycosides and HPLC and UPLC Quantification of Commercial Astragali Complanati Semen. Molecules. 2020 doi:10.3390/molecules25204762
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice